Mezera 1 g (Mesalazine FOAM) 1 G

Mezera 1G foam is a rectal application containing mesalazine, used for managing inflammatory conditions. This 14-application pack offers targeted relief with a 1g strength per dose.

Strength

1 G

Pack Size

14 ACT

Manufacturer / TM Owner

AVIR PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mezera 1G foam is primarily used for managing symptoms associated with inflammatory conditions of the rectum. It is applied rectally to help alleviate discomfort and promote healing. This foam formulation is designed for localized treatment, making it suitable for conditions requiring direct application to the affected area.

Side Effects

When used as directed, Mezera 1G foam may help reduce inflammation and soothe the rectal area. Some users might experience temporary relief from discomfort, though individual responses can vary. It is important to follow the instructions provided by a healthcare professional.

Precautions & Warnings

Before using Mezera 1G foam, consult a healthcare provider to ensure it is appropriate for your condition. Avoid using this product if you are allergic to mesalazine or any of its components. Always follow the recommended application guidelines to minimize the risk of irritation or adverse effects.

Avoid Interactions

Mezera 1G foam may interact with certain medications, including other rectal treatments or systemic drugs. Inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, avoid using alcohol-based products in the rectal area while using this foam.

Frequently Asked Questions

Mezera 1G foam is used for managing symptoms associated with inflammatory conditions of the rectum, providing localized relief.

Mezera 1G foam should be applied rectally as directed by a healthcare professional, ensuring proper dosage and application technique.

Common side effects may include temporary discomfort or irritation at the application site, though individual responses can vary.

Consult a healthcare provider before using Mezera 1G foam with other medications to avoid potential interactions.

The safety of long-term use should be discussed with a healthcare provider, who can assess the appropriateness based on individual health conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.